Full Text View
Tabular View
No Study Results Posted
Related Studies
A Trial of Rosiglitazone for Ulcerative Colitis
This study has been completed.
Study NCT00065065   Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First Received: July 16, 2003   Last Updated: March 31, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Ulcerative Colitis
Inflammatory Bowel Disease
Additional conditions recognized in this trial
Colitis
Colitis, Ulcerative
Inflammatory Bowel Diseases
Intestinal Diseases
Ulcer
More general conditions related to this trial
Colonic Diseases
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Pathologic Processes
Interventions listed in this trial
rosiglitazone (Avandia)
Additional drug interventions recognized in this trial
Rosiglitazone
More general drug interventions related to this trial
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services